Literature DB >> 16118811

Single patient (n-of-1) trials with binary treatment preference.

P J Schluter1, R S Ware.   

Abstract

The use of a fully parametric Bayesian method for analysing single patient trials based on the notion of treatment 'preference' is described. This Bayesian hierarchical modelling approach allows for full parameter uncertainty, use of prior information and the modelling of individual and patient sub-group structures. It provides updated probabilistic results for individual patients, and groups of patients with the same medical condition, as they are sequentially enrolled into individualized trials using the same medication alternatives. Two clinically interpretable criteria for determining a patient's response are detailed and illustrated using data from a previously published paper under two different prior information scenarios. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16118811     DOI: 10.1002/sim.2132

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  12 in total

1.  Bayesian credible intervals for binomial proportions in a single patient trial.

Authors:  Jacob J Oleson
Journal:  Stat Methods Med Res       Date:  2010-02-24       Impact factor: 3.021

2.  N-of-1 Randomized Intervention Trials in Health Psychology: A Systematic Review and Methodology Critique.

Authors:  Jonathan A Shaffer; Ian M Kronish; Louise Falzon; Ying Kuen Cheung; Karina W Davidson
Journal:  Ann Behav Med       Date:  2018-08-16

3.  What ever happened to N-of-1 trials? Insiders' perspectives and a look to the future.

Authors:  Richard L Kravitz; Naihua Duan; Edmund J Niedzinski; M Cameron Hay; Saskia K Subramanian; Thomas S Weisner
Journal:  Milbank Q       Date:  2008-12       Impact factor: 4.911

4.  Conducting research in individual patients: lessons learnt from two series of N-of-1 trials.

Authors:  Anke C M Wegman; Daniëlle A W M van der Windt; Wim A B Stalman; Theo P G M de Vries
Journal:  BMC Fam Pract       Date:  2006-09-19       Impact factor: 2.497

5.  Do pilocarpine drops help dry mouth in palliative care patients: a protocol for an aggregated series of n-of-1 trials.

Authors:  Jane Nikles; Geoffrey K Mitchell; Janet Hardy; Meera Agar; Hugh Senior; Sue-Ann Carmont; Philip J Schluter; Phillip Good; Rohan Vora; David Currow
Journal:  BMC Palliat Care       Date:  2013-10-31       Impact factor: 3.234

6.  A comparison of four methods for the analysis of N-of-1 trials.

Authors:  Xinlin Chen; Pingyan Chen
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

Review 7.  Methodological Considerations in N-of-1 Trials of Traditional Chinese Medicine.

Authors:  Haiyin Huang; Jiaqi An; Lizhi Lu; Mingli Wang; Huijia Chen; Xinlin Chen; Lihua Shen
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-23       Impact factor: 2.629

8.  Using aggregated single patient (N-of-1) trials to determine the effectiveness of psychostimulants to reduce fatigue in advanced cancer patients: a rationale and protocol.

Authors:  Hugh Ej Senior; Geoffrey K Mitchell; Jane Nikles; Sue-Ann Carmont; Philip J Schluter; David C Currow; Rohan Vora; Michael J Yelland; Meera Agar; Phillip D Good; Janet R Hardy
Journal:  BMC Palliat Care       Date:  2013-04-23       Impact factor: 3.234

9.  Central nervous system stimulants for secondary attention deficit-hyperactivity disorder after paediatric traumatic brain injury: a rationale and protocol for single patient (n-of-1) multiple cross-over trials.

Authors:  Hugh E J Senior; Lynne McKinlay; Jane Nikles; Philip J Schluter; Sue-Ann Carmont; Mary-Clare Waugh; Adrienne Epps; Owen Lloyd; Geoffrey K Mitchell
Journal:  BMC Pediatr       Date:  2013-05-28       Impact factor: 2.125

10.  Aggregated n-of-1 trials of central nervous system stimulants versus placebo for paediatric traumatic brain injury--a pilot study.

Authors:  Catherine J Nikles; Lynne McKinlay; Geoffrey K Mitchell; Sue-Ann S Carmont; Hugh E Senior; Mary-Clare A Waugh; Adrienne Epps; Philip J Schluter; Owen T Lloyd
Journal:  Trials       Date:  2014-02-13       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.